Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection. (Q38521437)
Jump to navigation
Jump to search
scientific article published on December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection. |
scientific article published on December 2002 |
Statements
Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection (English)
Tae-Yoon Kim
Han-Jeong Myoung
Ji-Hyun Kim
In-Sung Moon
Tai-Gyu Kim
Woong-Shick Ahn
1 December 2002